Get AUVI-Q for $0 out-of-pocket

Eligibility details

It’s pocket-sized.
It has voice instructions.
And it has an auto-retractable needle.

AUVI-Q® (epinephrine injection, USP) is available in three strengths:

*Based on IMS prescription data September 2017 – June 2018 (AUVI-Q 0.15 mg and 0.3 mg).

Developed by Patients, for Patients.®

AUVI-Q was developed using Human Factors Engineering, incorporating real-world experience and feedback from people with life-threatening allergies and their caregivers.

It is designed to be easy to use, and to help maximize the safe administration of epinephrine and minimize the potential for use-related errors during injection.

Growing up with life-threatening allergies The idea for AUVI-Q

Putting AUVI-Q to the test:
Helping patients understand how to use their AUVI-Q.

100% of adults and 95% of pediatric patients were able to complete a simulated injection with AUVI-Q on the first attempt in a design validation and labeling comprehension study, without committing a critical use error or receiving any training from a healthcare practitioner.17

100% of adults & 95% of pediatric patients

were able to complete a simulated injection with AUVI-Q on the first attempt.17

Designed with size in mind.

About the size of a credit card and thickness of a cell phone, AUVI-Q fits in most pockets, small purses, and diaper bags.

The first and only epinephrine auto-injector with an auto-retractable needle.

The AUVI-Q auto-retractable needle is not visible before, during, or after injection, and completes epinephrine injection in seconds.

Epinephrine injection is complete in less than half a second. However, you must push firmly and hold for a complete 2-second count.

If you inject a young child or infant with AUVI-Q, hold their leg firmly in place before and during the injection to prevent injuries. Ask your healthcare provider to show you how to properly hold the leg of a young child or infant during an injection.11

Take a closer look




— thigh muscle —

Get to know the AUVI-Q voice.

AUVI-Q contains an electronic voice instruction system to help guide users through the entire epinephrine injection.11

A 2-second countdown begins after AUVI-Q is activated. Voice instructions will indicate the injection is complete, AUVI-Q will beep, and the lights will blink red. After use, seek immediate medical attention.11

AUVI-Q was designed to be easy to use.

Watch the instructional video
Step 1: Pull AUVI-Q up from the outer case.

Do not go to Step 2 until you are ready to use AUVI-Q. If you are not ready to use AUVI-Q, put it back in the outer case.

Step 2: Pull Red safety guard down and off of AUVI-Q.

To reduce the chance of an accidental injection, do not touch the black base of the auto-injector, which is where the needle comes out. If an accidental injection happens, get medical help right away.

Note: The red safety guard is made to fit tight. Pull firmly to remove.

Step 3: Place black end of AUVI-Q against the middle of the outer thigh, then push firmly until you hear a click and hiss sound, and hold in place for 2 seconds.

AUVI-Q can inject through clothing, if necessary. ONLY inject into the middle of the outer thigh.

To minimize the risk of injection-related injury when administering AUVI-Q to young children or infants, remember to hold a child’s leg in place during an injection with AUVI-Q and limit movement prior to and during injection.


AUVI-Q® (epinephrine injection, USP) is a prescription medicine used to treat life-threatening allergic reactions, including anaphylaxis, in people who are at risk for or have a history of serious allergic reactions.

Important Safety Information

AUVI-Q is for immediate self (or caregiver) administration and does not take the place of emergency medical care. Seek immediate medical treatment after using AUVI-Q. Each AUVI-Q contains a single dose of epinephrine. AUVI-Q should only be injected into your outer thigh, through clothing if necessary. If you inject a young child or infant with AUVI-Q, hold their leg firmly in place before and during the injection to prevent injuries. Do not inject AUVI-Q into any other part of your body, such as into veins, buttocks, fingers, toes, hands, or feet. If this occurs, seek immediate medical treatment and make sure to inform the healthcare provider of the location of the accidental injection. Only a healthcare provider should give additional doses of epinephrine if more than two doses are necessary for a single allergic emergency.

Rarely, patients who use AUVI-Q may develop infections at the injection site within a few days of an injection. Some of these infections can be serious. Call your healthcare provider right away if you have any of the following symptoms at an injection site: redness that does not go away, swelling, tenderness, or the area feels warm to the touch.

If you have certain medical conditions, or take certain medicines, your condition may get worse or you may have more or longer lasting side effects when you use AUVI-Q. Be sure to tell your healthcare provider about all the medicines you take, especially medicines for asthma. Also tell your healthcare provider about all of your medical conditions, especially if you have asthma, a history of depression, thyroid problems, Parkinson’s disease, diabetes, heart problems or high blood pressure, have any other medical conditions, are pregnant or plan to become pregnant, or are breastfeeding or plan to breastfeed. Epinephrine should be used with caution if you have heart disease or are taking certain medicines that can cause heart-related (cardiac) symptoms.

Common side effects include fast, irregular or ‘pounding’ heartbeat, sweating, shakiness, headache, paleness, feelings of over excitement, nervousness, or anxiety, weakness, dizziness, nausea and vomiting, or breathing problems. These side effects usually go away quickly, especially if you rest. Tell your healthcare provider if you have any side effect that bothers you or that does not go away.

You are encouraged to report negative side effects of prescription drugs to the FDA. Visit or call 1-800-FDA-1088.